Conference Coverage

Outcomes of Screening for Distress in Veterans with Cancer

Barber J, Rose M, Connery D, Doris D, Beck J, Forte R, Humanick C.

Abstract 21: 2014 AVAHO Meeting


 

References

Purpose: The importance of psychosocial care for veterans with cancer highlights the need for a systematic approach to screening for psychosocial distress. A multidisciplinary team at the Comprehensive Cancer Center (CCC) at the VA Connecticut Healthcare System in West Haven, Connecticut, has formalized a process of distress screening.

Methods: We will present data from the first year of screening, including (1) patterns of distress in veterans with cancer, including (a) changes over time; and (b) patterns related to type/stage of malignancy; (2) impact of screening on number of referrals/completed consults to members of the multidisciplinary team; and (3) whether patterns in consults/referral changed after the addition of a computerized template to capture screening data in our medical record. This project was reviewed by our local Human Investigation Committee and deemed to be quality improvement and exempt from review. Patients receiving services within the CCC completed a distress screening form at each visit. Completed screens were documented in the CPRS in a computerized template and entered into a database. Data will be extracted from the cancer registry and from the medical record on type and stage of malignancy, demographic variables, and on number and types of consults generated and completed for each veteran with at least one completed screen.

Preliminary Results: Five hundred unique veterans were screened in year 1. Valid distress scores were available for 397 patients. One hundred five veterans had documented screens at 2 time points (T1 and T2), which are separated by a mean of 85.9 days (SD = 65.77). Mean distress score at T1 was 3.01 (SD = 3.01). At T1, 169 (40.3%) rated distress as > 4; and 134 (33.8%) rated distress as > 5. The mean distress score T2 was 3.01 (SD = 3.09). At T2, 27 (34.2%) rated distress as > 4; and 24 (30.4%) rated distress as > 5. Twenty-two (31%) increased from T1 to T2 with 16 (72.7%) increasing to > 4. Six (8.5%) were below clinical cutoffs at T1 but > 4 at T2. Twenty-two (31%) decreased from T1 to T2; 19 (86.4%) decreased to < 3. Twenty-seven (38%) did not change from T1 to T2. Distress screening resulted in an increase in consults to members of the multidisciplinary team (Clinical Health Psychology, Nutrition, Physical/Occupational Therapy, and Social Work). Nine consults were performed per month prescreening vs 14.4 per month after start of screening vs 22.75 per month after the addition of the computerized screening template in CPRS. Data on types of problems, relationship to type/stage of malignancy, and additional detail on pattern of consults will be presented.

Conclusions: Rates of clinically significant distress among veterans treated at the VA Connecticut Healthcare System are on par with rates noted in the literature. Distress measured by National Comprehensive Cancer Network Distress Thermometer changes over time highlighted the need for routine screening. The impact of screening on medical center resources as evidenced by the number of referrals to members of the multidisciplinary team and completed consults will be examined.

Recommended Reading

Setting up a Cancer Genetic Risk Evaluation Clinic in a VAMC
Federal Practitioner
Chemotherapy Ordering Management System
Federal Practitioner
Oral Antineoplastic Therapy Adherence and Adverse Events: A Quality Assessment Project at the Providence VAMC
Federal Practitioner
VHA and Reproductive Health: Addressing Fertility Risk Factors and Preservation Options for Veterans With Cancer
Federal Practitioner
Implementation of the Cancer Care Coordination Program in the Veterans Affairs Hospital: Sharing Our Experience and What We Have Learned
Federal Practitioner
Using Reminder Dialog Templates to Monitor Cancer Care
Federal Practitioner
Reproducible Complete Remission of Advanced Hepatocellular Carcinoma With Sorafenib in Combination With Clopidogrel
Federal Practitioner
Systemic Therapy Use in Stage IV Pancreatic Cancer: Comparison Between VA Nebraska-Western Iowa and National Database, Using National Cancer Data Base Analysis
Federal Practitioner
National Cancer Care Cube
Federal Practitioner
Trend of Esophageal Squamous Cell Carcinoma in the 21st Century: An Analysis of the SEER 18 Database
Federal Practitioner